All In Biotech

Drug Trial Radar · NCT06435221

Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers

A Multicenter, Open-Label Study Assessing Long-Term Exposure With Cytisinicline 3 mg TID

Last checked: Nov 20, 2026Latest source record: Nov 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

479

Actual

Start

May 28, 2024

Primary completion

Sep 29, 2025

Study completion Oct 6, 2025

Sponsor

Lead sponsor
Achieve Life SciencesIndustry
Sponsor type
Industry
First posted
May 30, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Safety assessment of long-term 3 mg cytisinicline three times daily (TID) exposure for 52 weeks is the main purpose of this study, conducted in the United States.

Conditions

  • Smoking Cessation
  • Vaping Cessation

Interventions

  • CytisiniclineDrug

    film-coated oral tablets containing 3 mg cytisinicline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence Rate of Treatment Emergent Serious Adverse Events (SAEs)Time frame: up to Week 52

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • Alliance for Multispecialty Research, LLC

    Mobile, Alabama

  • Alliance for Multispecialty Research, LLC

    Tempe, Arizona

  • Little Rock Allergy & Asthma Clinical Research Center

    Little Rock, Arkansas

  • Alliance for Multispecialty Research, LLC

    Coral Gables, Florida

  • Accel Research Sites Network - DeLand Clinical Research Unit

    DeLand, Florida

  • Alliance for Multispecialty Research, LLC

    Fort Myers, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Precision Clinical Research

    Sunrise, Florida

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Alliance for Multispecialty Research, LLC

    Oak Brook, Illinois

  • MediSphere Medical Research Center, LLC

    Evansville, Indiana

  • Alliance for Multispecialty Research, LLC

    Wichita, Kansas

  • Alliance for Multispecialty Research, LLC

    Lexington, Kentucky

  • Alliance for Multispecialty Research, LLC

    New Orleans, Louisiana

  • Massachusetts General Hospital - Clinical Genetic Facility

    Boston, Massachusetts

  • Insight Research Institute

    Flint, Michigan

  • Alliance for Multispecialty Research, LLC

    Kansas City, Missouri

  • Alliance for Multispecialty Research, LLC

    Las Vegas, Nevada

  • Global Medical Institutes LLC; Princeton Medical Institute

    Princeton, New Jersey

  • Rochester Clinical Research, LLC

    Rochester, New York

  • Centricity Research Columbus Ohio Multispecialty

    Columbus, Ohio

  • Alliance for Multispecialty Research, LLC

    Norman, Oklahoma

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania

  • Coastal Carolina Research Center

    North Charleston, South Carolina

  • Alliance for Multispecialty Research, LLC

    Knoxville, Tennessee

  • Clinical Research Associates, Inc.

    Nashville, Tennessee

  • Clinical Trials of Texas, LLC

    San Antonio, Texas

  • Health Research of Hampton Roads, Inc.

    Newport News, Virginia

  • Alliance for Multispecialty Research, LLC

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.